glp-1 cardiovascular outcome trials and mortality outcomes with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia An Observational Study of Cardiovascular
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] [233].Chen B, Yu X, Horvath-Diano C, Ortuo MJ, Tschp MH, Jastreboff AM, et al
You can speak to your GP or an obesity specialist, or use a regulated online weight-loss clinic such as Slimbr start with a free online eligibility quiz, and if a clinician confirms it's appropriate for you, they can issue a prescription and guide you to a partner pharmacy
Endocr Pract (2016) 22 Suppl 3:1203
The most commonly reported adverse events were gastrointestinal-related and generally mild to moderate in severity
